Literature DB >> 33789013

Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.

Rita R Kalyani1.   

Abstract

Entities:  

Year:  2021        PMID： 33789013     DOI： 10.1056/NEJMcp2000280

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  Glycated Hemoglobin as an Integrator of Cardiovascular Risk in Individuals Without Diabetes: Lessons from Recent Epidemiologic Studies.

Authors:  Alexander P Hoffmann; Michael C Honigberg
Journal:  Curr Atheroscler Rep       Date:  2022-04-07       Impact factor: 5.113

Review 2.  Interpreting Absolute and Relative Risk Reduction in the Context of Recent Cardiovascular Outcome Trials in Patients with Type 2 Diabetes.

Authors:  David D Berg; Ahmed A Kolkailah; Ashish Sarraju; Anne Marie Kerchberger; Mahmoud Eljalby; Darren K McGuire
Journal:  Curr Diab Rep       Date:  2021-11-06       Impact factor: 4.810

3.  Temporal patterns of multi-morbidity in 570157 ischemic heart disease patients: a nationwide cohort study.

Authors:  Amalie D Haue; Jose J Almagro Armenteros; Peter C Holm; Robert Eriksson; Pope L Moseley; Lars V Køber; Henning Bundgaard; Søren Brunak
Journal:  Cardiovasc Diabetol       Date:  2022-05-31       Impact factor: 8.949

Review 4.  Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Authors:  Amir Razaghizad; Emily Oulousian; Varinder Kaur Randhawa; João Pedro Ferreira; James M Brophy; Stephen J Greene; Julian Guida; G Michael Felker; Marat Fudim; Michael Tsoukas; Tricia M Peters; Thomas A Mavrakanas; Nadia Giannetti; Justin Ezekowitz; Abhinav Sharma
Journal:  J Am Heart Assoc       Date:  2022-05-16       Impact factor: 6.106

5.  SGLT2 inhibitors in cardiovascular medicine.

Authors:  Fahimeh Varzideh; Urna Kansakar; Gaetano Santulli
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2021-07-23

6.  Cardiovascular and Kidney Outcomes Across the Glycemic Spectrum: Insights From the UK Biobank.

Authors:  Michael C Honigberg; Seyedeh M Zekavat; James P Pirruccello; Pradeep Natarajan; Muthiah Vaduganathan
Journal:  J Am Coll Cardiol       Date:  2021-05-17       Impact factor: 27.203

7.  Renal transplant outcomes and diabetes.

Authors:  Larry A Weinrauch; John A D'Elia
Journal:  BMJ Open Diabetes Res Care       Date:  2021-05

Review 8.  A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan.

Authors:  Ibrahim Mohammed; Morley D Hollenberg; Hong Ding; Chris R Triggle
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-05       Impact factor: 5.555

Review 9.  Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment.

Authors:  Matilda Florentin; Michael S Kostapanos; Athanasia K Papazafiropoulou
Journal:  World J Diabetes       Date:  2022-02-15

Review 10.  An Autonomous Cannabinoid System in Islets of Langerhans.

Authors:  Kanikkai Raja Aseer; Josephine M Egan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-05       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.